ClinVar Genomic variation as it relates to human health
NM_001077365.2(POMT1):c.1136_1137dup (p.Gln380fs)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001077365.2(POMT1):c.1136_1137dup (p.Gln380fs)
Variation ID: 2951641 Accession: VCV002951641.1
- Type and length
-
Duplication, 2 bp
- Location
-
Cytogenetic: 9q34.13 9: 131513290-131513291 (GRCh38) [ NCBI UCSC ] 9: 134388677-134388678 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Feb 29, 2024 Feb 28, 2024 Sep 5, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_001077365.2:c.1136_1137dup MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001070833.1:p.Gln380fs frameshift NM_001077366.2:c.974_975dup NP_001070834.1:p.Gln326fs frameshift NM_001136113.2:c.1136_1137dup NP_001129585.1:p.Gln380fs frameshift NM_001136114.2:c.785_786dup NP_001129586.1:p.Gln263fs frameshift NM_001353193.2:c.1202_1203dup NP_001340122.2:p.Gln402fs frameshift NM_001353194.2:c.974_975dup NP_001340123.1:p.Gln326fs frameshift NM_001353195.2:c.785_786dup NP_001340124.1:p.Gln263fs frameshift NM_001353196.2:c.1046_1047dup NP_001340125.1:p.Gln350fs frameshift NM_001353197.2:c.1040_1041dup NP_001340126.2:p.Gln348fs frameshift NM_001353198.2:c.1040_1041dup NP_001340127.2:p.Gln348fs frameshift NM_001353199.2:c.851_852dup NP_001340128.2:p.Gln285fs frameshift NM_001353200.2:c.680_681dup NP_001340129.1:p.Gln228fs frameshift NM_001374689.1:c.1124_1125dup NP_001361618.1:p.Gln376fs frameshift NM_001374690.1:c.1136_1137dup NP_001361619.1:p.Gln380fs frameshift NM_001374691.1:c.785_786dup NP_001361620.1:p.Gln263fs frameshift NM_001374692.1:c.785_786dup NP_001361621.1:p.Gln263fs frameshift NM_001374693.1:c.824+1825_824+1826dup intron variant NM_001374695.1:c.746_747dup NP_001361624.1:p.Gln250fs frameshift NM_001411024.1:c.5_6dup NP_001397953.1:p.Gln3fs frameshift NM_007171.4:c.1202_1203dup NP_009102.4:p.Gln402fs frameshift NR_148391.2:n.1170_1171dup non-coding transcript variant NR_148392.2:n.1388_1389dup non-coding transcript variant NR_148393.2:n.1170_1171dup non-coding transcript variant NR_148394.2:n.1063_1064dup non-coding transcript variant NR_148395.2:n.1322_1323dup non-coding transcript variant NR_148396.2:n.956_957dup non-coding transcript variant NR_148397.2:n.1220_1221dup non-coding transcript variant NR_148398.2:n.1175_1176dup non-coding transcript variant NR_148399.2:n.1562_1563dup non-coding transcript variant NR_148400.2:n.1161_1162dup non-coding transcript variant NC_000009.12:g.131513292_131513293dup NC_000009.11:g.134388679_134388680dup NG_008896.2:g.15391_15392dup NG_117886.1:g.574_575dup NG_117887.1:g.73_74dup LRG_842:g.15391_15392dup LRG_842t1:c.1202_1203dup LRG_842p1:p.Gln402fs LRG_842t2:c.1136_1137dup LRG_842p2:p.Gln380fs - Protein change
- Q326fs, Q228fs, Q263fs, Q285fs, Q350fs, Q376fs, Q380fs, Q402fs, Q250fs, Q348fs, Q3fs
- Other names
- -
- Canonical SPDI
- NC_000009.12:131513290:GTG:GTGTG
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
POMT1 | - | - |
GRCh38 GRCh37 |
1160 | 1201 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (1) |
criteria provided, single submitter
|
Sep 5, 2023 | RCV003812328.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Sep 05, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1
Walker-Warburg congenital muscular dystrophy Autosomal recessive limb-girdle muscular dystrophy type 2K
Explanation for multiple conditions: Uncertain.
The variant was classified for several related diseases, possibly a spectrum of disease; the variant may be associated with one or more the diseases.
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV004607047.1
First in ClinVar: Feb 28, 2024 Last updated: Feb 28, 2024 |
Comment:
For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with POMT1-related conditions. … (more)
For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with POMT1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln402Cysfs*7) in the POMT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POMT1 are known to be pathogenic (PMID: 12369018, 15637732, 16575835). (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
The expanding phenotype of POMT1 mutations: from Walker-Warburg syndrome to congenital muscular dystrophy, microcephaly, and mental retardation. | van Reeuwijk J | Human mutation | 2006 | PMID: 16575835 |
Mutations in POMT1 are found in a minority of patients with Walker-Warburg syndrome. | Currier SC | American journal of medical genetics. Part A | 2005 | PMID: 15637732 |
Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. | Beltrán-Valero de Bernabé D | American journal of human genetics | 2002 | PMID: 12369018 |
Text-mined citations for this variant ...
HelpRecord last updated Sep 30, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.